Finland
Galena Pharma Oy, founded in 1996, is a Finland-based pharmaceutical company recognized for its agility and substantial expertise, encapsulated in their slogan, "Big in expertise, agile in action." Specializing in the development and manufacturing of substance-based medical devices, the company emphasizes its compliance with GMP and the EU MDR, ensuring high-quality standards.
Galena Pharma offers a diverse range of services: from ready-to-market medical devices available for in-licensing to extensive research and development, and comprehensive production and tech transfer services. Their product portfolio spans key health sectors, including gastrointestinal health, female intimate care, and more, serving a global customer base with over 50 MDR-certified SKUs.
Having transitioned to EU MDR standards in 2020 and held ISO 13485 certification since 2013, Galena Pharma operates two modern manufacturing facilities. The company's most recent funding was a Private Equity Round from Intera Partners on 01 January 2021, underscoring investor confidence in their robust capabilities and global reach.
